Drug Type Small molecule drug |
Synonyms LE SN38, SN-38 liposomal |
Target |
Mechanism TOP1 inhibitors(DNA topoisomerase I inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedPhase 2 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Colorectal Cancer | Phase 2 | US | - | - |
Colorectal Cancer | Phase 2 | - | - | |
Neoplasms | Phase 1 | US | 01 Oct 2002 |
Phase 1/2 | 114 | DEP SN38 monotherapy Q3W | tvslcqlhoe(ymmpdtatbp) = 1 event of G3 diarrhea (0.9% pts) tzvsbyssll (btnvvmxier ) View more | Positive | 24 May 2024 | ||
DEP SN38 monotherapy Q2W | |||||||
Phase 2 | 30 | rnyyvifkim(iovtsoukln) = iaoutdfbuw soatsieuit (ixazelbmwv ) View more | Negative | 20 May 2008 |